In this scenario, dysregulation of Rab34 levels and/or localization, as demonstrated herein for obesity conditions, could contribute, at least in part, to both the changes in the secretory profile and impaired lipid metabolism that characterize adipocyte dysfunction in obesity. This evidence concerns the gene RAB34 and obesity disorder.